Immuno Oncology Assays Market - 2024-2033

May 2025 | 217 pages | ID: I5669ECE9F23EN
DataM Intelligence

Abstracts

The Immuno Oncology Assays Market was valued at US$ 6.11 Billion in 2024 and is anticipated to reach US$ 17.96 Billion by 2033, at a CAGR of 0.128 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Immuno Oncology Assays Market.

This report delivers a comprehensive overview of the Immuno Oncology Assays Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Immuno Oncology Assays Market. The Immuno Oncology Assays Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.

Immuno Oncology Assays Market Scope:

Major Highlights

This report delivers a comprehensive overview of the Immuno Oncology Assays Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Immuno Oncology Assays Market. The Immuno Oncology Assays Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification

• Increase Your Customer Base by 3X using our Partner Identification tool
• Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
• Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
• Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?

• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Contents

1. MARKET INTRODUCTION AND SCOPE

1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope

2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS

3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS

3.1. Key Trends and Future Projections

4. SNIPPET BY TYPE

4.1. Snippet by Treatment
4.2. Snippet by Route of Administration
4.3. Snippet by Region

5. DYNAMICS

5.1. Impacting Factors
  5.1.1. Drivers
    5.1.1.1. Increasing Developments in Immuno-Oncology Sector
    5.1.1.2. Rising Prevalence of Cancer
  5.1.2. Restraints
    5.1.2.1. High Cost of Assays
    5.1.2.2. Competition from Alternative Cancer Screening Methods
    5.1.2.3. XX
  5.1.3. Opportunity
    5.1.3.1. Collaborations and Partnerships Among the Companies
    5.1.3.2. XX
  5.1.4. Impact Analysis

6. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK

6.1. Market Leaders and Pioneers
  6.1.1. Emerging Pioneers and Prominent Players
  6.1.2. Established Leaders with Largest Marketing Brand
  6.1.3. Market Leaders with Established Products
6.2. Latest Developments and Breakthroughs
6.3. Regulatory and Reimbursement Landscape
  6.3.1. North America
  6.3.2. Europe
  6.3.3. Asia Pacific
  6.3.4. Latin America
  6.3.5. Middle East & Africa
6.4. Porter’s Five Forces Analysis
6.5. Supply Chain Analysis
6.6. Patent Analysis
6.7. SWOT Analysis
6.8. Pipeline Analysis
6.9. Epidemiology Analysis
6.10. Unmet Needs and Gaps
6.11. Recommended Strategies for Market Entry and Expansion
6.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
6.13. Pricing Analysis and Price Dynamics
6.14. Key Opinion Leaders

7. IMMUNO-ONCOLOGY ASSAYS MARKET PRODUCT TYPE OUTLOOK

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  7.1.2. Market Attractiveness Index, By Product Type
7.2. Instruments*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Consumables
7.4. Software and Services

8. IMMUNO-ONCOLOGY ASSAYS MARKET ASSAY TYPE OUTLOOK

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Assay Type
  8.1.2. Market Attractiveness Index, By Assay Type
8.2. Cell Proliferation Assays*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Cell Migration and Invasion Assays
8.4. Phagocytosis Assays
8.5. Immune Cell Killing Assays
8.6. Others

9. IMMUNO-ONCOLOGY ASSAYS MARKET TECHNOLOGY OUTLOOK

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  9.1.2. Market Attractiveness Index, By Technology
9.2. PCR*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. NGS
9.4. Immunoassay
9.5. Flow Cytometry
9.6. Others

10. IMMUNO-ONCOLOGY ASSAYS MARKET INDICATION OUTLOOK

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  10.1.2. Market Attractiveness Index, By Indication
10.2. Colorectal Cancer*
  10.2.1. Introduction
  10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Breast Cancer
10.4. Lung Cancer
10.5. Melanoma
10.6. Others

11. IMMUNO-ONCOLOGY ASSAYS MARKET END USER OUTLOOK

11.1. Introduction
  11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  11.1.2. Market Attractiveness Index, By End User
11.2. Academic Institutes*
  11.2.1. Introduction
  11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Research Organizations
11.4. Diagnostics Centers
11.5. Others

12. IMMUNO-ONCOLOGY ASSAYS MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES

13. INTRODUCTION

13.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  13.1.1. Market Attractiveness Index, By Region
13.2. North America
  13.2.1. Introduction
  13.2.2. Key Region-Specific Dynamics
  13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Assay Type
  13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

14. MARKET SIZE ANALYSIS AND Y-O-Y GROWTH ANALYSIS (%), BY COUNTRY

14.1. U.S.
  14.1.1. Canada
    14.1.1.1. Mexico
14.2. Europe
  14.2.1. Introduction
  14.2.2. Key Region-Specific Dynamics
  14.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  14.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Assay Type
  14.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  14.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  14.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  14.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    14.2.8.1. Germany
    14.2.8.2. UK
    14.2.8.3. France
    14.2.8.4. Spain
    14.2.8.5. Italy
    14.2.8.6. Rest of Europe
14.3. Asia-Pacific
  14.3.1. Introduction
  14.3.2. Key Region-Specific Dynamics
  14.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  14.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Assay Type
  14.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  14.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  14.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  14.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    14.3.8.1. China
    14.3.8.2. India
    14.3.8.3. Japan
    14.3.8.4. South Korea
    14.3.8.5. Rest of Asia-Pacific
14.4. South America
  14.4.1. Introduction
  14.4.2. Key Region-Specific Dynamics
  14.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  14.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Assay Type
  14.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  14.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  14.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  14.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    14.4.8.1. Brazil
    14.4.8.2. Argentina
    14.4.8.3. Rest of South America
14.5. Middle East and Africa
  14.5.1. Introduction
  14.5.2. Key Region-Specific Dynamics
  14.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  14.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Assay Type
  14.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  14.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  14.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

15. COMPETITIVE LANDSCAPE AND MARKET POSITIONING

16. COMPETITIVE OVERVIEW AND KEY MARKET PLAYERS

16.1. Market Share Analysis and Positioning Matrix
16.2. Strategic Partnerships, Mergers & Acquisitions
16.3. Key Developments in Product Portfolios and Innovations
16.4. Company Benchmarking

17. COMPANY PROFILES

Key Players

1. MERCK KGAA*

1.1. Company Overview
  1.1.1. Product Portfolio
    1.1.1.1. Product Description
    1.1.1.2. Product Key Performance Indicators (KPIs)
    1.1.1.3. Historic and Forecasted Product Sales
    1.1.1.4. Product Sales Volume

2. FINANCIAL OVERVIEW

2.1. Company Revenue
  2.1.1. Geographical Revenue Shares
    2.1.1.1. Revenue Forecasts
  2.1.2. Key Developments
    2.1.2.1. Mergers & Acquisitions
    2.1.2.2. Key Product Development Activities
    2.1.2.3. Regulatory Approvals, etc.
  2.1.3. SWOT Analysis
2.2. Thermo Fisher Scientific Inc.
2.3. Lunaphore Technologies SA.
2.4. Eve Technologies.
2.5. Vivia Biotech S.L
2.6. Illumina, Inc.
2.7. Charles River Laboratories
2.8. Bio-Techne
2.9. Creative Biolabs
2.10. Miltenyi Biotec
2.11. Adipogen Life SciencesLIST NOT EXHAUSTIVE

3. ASSUMPTION AND RESEARCH METHODOLOGY

3.1. Data Collection Methods
3.2. Data Triangulation
3.3. Forecasting Techniques
3.4. Data Verification and Validation

4. APPENDIX

4.1. About Us and Services
4.2. Contact Us